AZGP1 deficiency promotes chronic kidney fibrosis in aging mice
Year: 2026
Type: article
Abstract: OBJECTIVES: Chronic kidney disease (CKD) affects 10-14% of the global population and is a leading cause of death. A hallmark of CKD is renal fibrosis, characterized by excessive extracellular matrix deposition. Although our understanding of fibrogenic mechanisms has advanced, effective antifibrotic therapies are lacking. Zinc-α2-glycoprotein 1 (AZGP1) regulates extracellular matrix remodeling in multiple organs, and we previously demonstrated that loss of AZGP1 induces fibrosis in the prostate. METHODS: mice were analyzed by hematoxylin and eosin (H&E), immunohistochemistry, and picrosirius red staining. RESULTS: mice, persisting through ten months. CONCLUSIONS: These findings identify AZGP1 expressed in proximal tubular cells as protective against kidney fibrosis associated with aging and is a candidate therapeutic target.
DOI: 10.62347/oxnv6046
Authors: Ru M Wen, Eric E Peterson, James D Brooks
Institutions: Stanford Medicine, Stanford University
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7204581386
